
Jeptrax S 1000mg/500mg Injection
Marketer
Kembris Pharmaceuticals
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Jeptrax S 1000mg/500mg Injection
Combiflox 1000mg/500mg injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administered solely under medical guidance, consistent adherence to the prescribed dosage is crucial for optimal efficacy; premature cessation may compromise treatment. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions necessitate immediate medical attention; similarly, allergic responses (skin rashes, pruritus, edema, respiratory distress) demand urgent consultation. Prior to commencing treatment, disclose all existing medications and pre-existing conditions to your physician. Pregnant or lactating individuals require specific medical counsel. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Rest, nutritious meals, and ample hydration are recommended to aid recovery. Monitoring may involve periodic blood tests or other diagnostic evaluations to assess treatment effectiveness.
Primary Ingredients of Jeptrax S 1000mg/500mg Injection
No text was provided to rewrite.
Uses of Jeptrax S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Jeptrax S 1000mg/500mg Injection:
Administering this medication will be handled by your physician or their qualified associate; self-medication is strictly prohibited.
Common Side effects of Jeptrax S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Jeptrax S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Jeptrax S 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Jeptrax S 1000mg/500mg Injection, offer a powerful antibacterial approach. Ceftriaxone, a key antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The inclusion of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Jeptrax S 1000mg/500mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Jeptrax S 1000mg/500mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, research involving human subjects is currently insufficient.
Breast feedingCAUTION
Administering Jeptrax S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Jeptrax S 1000mg/500mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Jeptrax S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The 1000mg/500mg Jeptrax S Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Jeptrax S 1000mg/500mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Jeptrax S 1000mg/500mg Injection :
Omit a dose of Jeptrax S 1000mg/500mg Injection? Seek medical advice immediately.
Facts to Know About Jeptrax S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Anti-Infective Agents |
